Malignant peripheral nerve sheath tumor with PRC2 loss-of-function was sensitive to BRD4 inhibitor, suggesting a promising therapeutic approach of SL-based BRD4 inhibition39. The gene discussed is BRD4; the disease is malignant peripheral nerve sheath tumor.